1.
Pourasghari H, Saberian P, Azari S, Omidi N, Arabloo J, Rajaie S, Rezaei MA, Behzadifar M, Tajdini M. The cost-effectiveness of Icosapent Ethyl for the Reduction of the Risk of Ischemic Cardiovascular Events: A systematic review. J Tehran Heart Cent. 2025;19(S1):40-55.